Upgrade to Pro — share decks privately, control downloads, hide ads and more …

Keynote Swiss Diagnostics Startup Day

Keynote Swiss Diagnostics Startup Day

Closing keynote to the annual innovation conference of Swiss Biolabs, Olten

Hannes Gassert

May 23, 2019
Tweet

More Decks by Hannes Gassert

Other Decks in Business

Transcript

  1. View Slide

  2. Hannes Gassert
    Civic Entrepreneur
    Startup Value(s)?
    Keynote Swiss Biolabs, 2019/5/23

    View Slide

  3. liip.ch
    wemakeit.com
    skim.com
    etoy.com
    liftconference.com
    opendata.ch
    powercoders.org
    sp-zuerich.ch
    crstl.io
    gassert.ch

    View Slide

  4. A reflection on health innovation
    from an outsider, to you insiders
    Startup Value(s)?

    View Slide

  5. Value?

    View Slide

  6. Value?

    View Slide

  7. Value?

    View Slide

  8. «A business model describes the
    rationale of how an organization
    creates, delivers, and captures
    value.»
    Alex Osterwalder & Yves Pigneur, 2011

    View Slide

  9. Quick survey, part 1:
    Who thinks health innovation
    is creating value?

    View Slide

  10. Quick survey, part 2:
    Who thinks health innovation
    is working well?

    View Slide

  11. «Hm.»
    Hannes Gassert, 2018

    View Slide

  12. Tamy Glauser, Candidate for the Swiss National Council (GP, ZH)

    View Slide

  13. View Slide

  14. View Slide

  15. View Slide

  16. CONCLUSION?

    View Slide

  17. View Slide

  18. SCIENCE WINTER?
    Reproducibility crisis

    View Slide

  19. PATENT WINTER?
    Intellectual property crisis

    View Slide

  20. Startup Value(s)?

    View Slide

  21. «Cui bono?»
    Seneca, 44 BCE

    View Slide

  22. «Between 2000 and 2011, only 4%
    of newly approved products were
    for neglected diseases that affect
    middle and low-income countries.»
    Pedrique, B. et al (2013)
    Lancet Global Health, 1(6):e371-379

    View Slide

  23. NORTH / SOUTH

    View Slide

  24. View Slide

  25. ED / PMS
    10x research on men’s
    issues vs. women’s issues

    View Slide

  26. View Slide

  27. PUBLIC / PRIVATE
    Public investment, private profit?

    View Slide

  28. View Slide

  29. «The current system for developing drugs
    incentivises high prices and delivers
    short-term returns to shareholders, rather
    than focusing on riskier, longer-term
    research which leads to critically needed
    therapeutic advances.»
    Mazzucato, M. et al (2018)
    The people’s prescription, UCL Institute for
    Innovation and Public Purpose Policy Report

    View Slide

  30. QUESTION:
    How to transform the current
    financialized health innovation
    model to be more long-term and
    “mission-oriented”?

    View Slide

  31. QUESTION:
    How to define the “purpose” of a
    broader model of health innovation
    based on public value and human
    rights?

    View Slide

  32. QUESTION:
    What will your diagnostics startups
    contribute to a health system that
    benefits all?

    View Slide

  33. Switzerland?

    View Slide

  34. View Slide

  35. Startup Value(s)?

    View Slide

  36. Purpose over profits
    Trust over control
    Practice over theory
    Risk over safety
    Flexibility over strength
    Open over closed
    Compasses over maps

    View Slide

  37. Startup Value(s)?

    View Slide

  38. CREATE MORE
    VALUE THAN
    YOU CAPTURE.

    View Slide

  39. Hannes Gassert
    @hannesgassert
    [email protected]
    Slides: http://liip.to/sbl19
    Merci.

    View Slide